Regeneron Pharmaceuticals
REGN
#285
Rank
A$117.42 B
Marketcap
A$1,108
Share price
1.62%
Change (1 day)
-8.87%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2025 (TTM): A$7.96 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are A$14.24 Billion. In 2024 the company made an earning of A$7.17 Billion, an increase over its 2023 earnings that were of A$6.30 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$7.96 B11.01%
2024 A$7.17 B13.83%
2023 A$6.30 B-13.57%
2022 A$7.29 B-47.9%
2021 A$14.00 B144.75%
2020 A$5.72 B56.86%
2019 A$3.64 B-4.87%
2018 A$3.83 B22.86%
2017 A$3.12 B56.3%
2016 A$1.99 B8.55%
2015 A$1.83 B54.53%
2014 A$1.19 B11.14%
2013 A$1.07 B72.13%
2012 A$0.62 B-285.93%
2011 -A$0.34 Billion121.73%
2010 -A$0.16 Billion37.18%
2009 -A$0.12 Billion-14.6%
2008 -A$0.13 Billion-25.02%
2007 -A$0.18 Billion6.32%
2006 -A$0.17 Billion-186.52%
2005 A$0.18 B2103.7%
2004 A$8.47 M-105.66%
2003 -A$0.15 Billion-18.18%
2002 -A$0.19 Billion42.33%
2001 -A$0.13 Billion129.35%
2000 -A$56.09 Million51.87%
1999 -A$36.94 Million92.19%
1998 -A$19.22 Million66.23%
1997 -A$11.57 Million-55.49%
1996 -A$25.98 Million103.53%
1995 -A$12.77 Million-70.89%
1994 -A$43.84 Million-26.08%
1993 -A$59.31 Million114.67%
1992 -A$27.63 Million196.77%
1991 -A$9.31 Million87.88%
1990 -A$4.96 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
A$12.37 B 60.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$0.19 B-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.85 B-62.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.63 B 529.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$24.64 B 219.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
A$13.66 B 76.87%๐Ÿ‡ซ๐Ÿ‡ท France